SINGULAR GENOMICS SYSTEMS IN (OMIC) Stock Price, Quote, News and Overview
NASDAQ:OMIC - Nasdaq - US82933R3084 - Common Stock - Currency: USD
OMIC Quote, Performance and Key Statistics
SINGULAR GENOMICS SYSTEMS IN
NASDAQ:OMIC (2/11/2025, 8:00:01 PM)
19.93
+0.02 (+0.1%)
The current stock price of OMIC is 19.93 USD. In the past month the price increased by 1.58%. In the past year, price increased by 21.36%.
OMIC Latest News and Analysis
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OMIC, CCRN, OMC on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OMIC, AMCR, ZUO on Behalf of Shareholders
OMIC Investors Have the Opportunity to Join Investigation of Singular Genomics Systems, Inc. with the Schall Law Firm
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA on Behalf of Shareholders
OMIC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.94 | 208.55B | ||
| DHR | DANAHER CORP | 26.92 | 145.63B | ||
| A | AGILENT TECHNOLOGIES INC | 26.8 | 40.43B | ||
| IQV | IQVIA HOLDINGS INC | 18.03 | 36.46B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 32.36 | 28.10B | ||
| WAT | WATERS CORP | 35.58 | 24.07B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 47.69 | 23.35B | ||
| ILMN | ILLUMINA INC | 41.09 | 15.97B | ||
| ICLR | ICON PLC | 13.35 | 15.47B | ||
| RVTY | REVVITY INC | 22.98 | 13.71B | ||
| AVTR | AVANTOR INC | 18.39 | 12.52B | ||
| TEM | TEMPUS AI INC | N/A | 11.21B |
Related stock screener links
About OMIC
Company Profile
Singular Genomics Systems Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 255 full-time employees. The company went IPO on 2021-05-27. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The firm has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The firm is also engaged in developing PX, which is a development-stage multiomics platform.
Company Info
SINGULAR GENOMICS SYSTEMS IN
3010 Science Park Road
San Diego CALIFORNIA US
CEO: Andrew Spaventa
Employees: 255
Company Website: https://singulargenomics.com/
Investor Relations: https://investor.singulargenomics.com/
Phone: 18583337830
OMIC FAQ
What is the stock price of OMIC?
The current stock price of OMIC is 19.93 USD.
What is the symbol for SINGULAR GENOMICS SYSTEMS IN stock?
The exchange symbol of SINGULAR GENOMICS SYSTEMS IN is OMIC and it is listed on the Nasdaq exchange.
On which exchange is OMIC stock listed?
OMIC stock is listed on the Nasdaq exchange.
Is OMIC a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for OMIC, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of OMIC.
Does OMIC stock pay dividends?
OMIC does not pay a dividend.
What is the Price/Earnings (PE) ratio of OMIC?
OMIC does not have a PE ratio as the earnings reported over the last twelve months were negative (-35.09).
What is the Short Interest ratio of OMIC stock?
The outstanding short interest for OMIC is 2.13% of its float.
OMIC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to OMIC. When comparing the yearly performance of all stocks, OMIC turns out to be only a medium performer in the overall market: it outperformed 60.87% of all stocks.
OMIC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OMIC. While OMIC seems to be doing ok healthwise, there are quite some concerns on its profitability.
OMIC Financial Highlights
Over the last trailing twelve months OMIC reported a non-GAAP Earnings per Share(EPS) of -35.09. The EPS increased by 8.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.27% | ||
| ROE | -70.04% | ||
| Debt/Equity | 0.04 |
OMIC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to OMIC. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 11.81% and a revenue growth 9.93% for OMIC